Concepedia

Alexandre Luneau

AL

6

Publications

235

Citations

6

H-Index

2016

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (United States)

Alexandre Luneau is an author at Novartis (Switzerland) specializing in engineering, biomolecular engineering, and biochemistry.

Top concepts

Publications per year

2016–2023

6

Publications

6

Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases

A. S. Nagle, Agnes Biggart, C. Be et al. · Journal of Medicinal Chemistry · 2020 · 111 citations · Full text

KAE609 (Cipargamin), a New Spiroindolone Agent for the Treatment of Malaria: Evaluation of the Absorption, Distribution, Metabolism, and Excretion of a Single Oral 300-mg Dose of [14C]KAE609 in Healthy Male Subjects

S.-E. W. Huskey, Chunqi Zhu, Andreas Fredenhagen et al. · Drug Metabolism and Disposition · 2016 · 35 citations

Comparison of 19F NMR and 14C Measurements for the Assessment of ADME of BYL719 (Alpelisib) in Humans

Alexander D. James, Cyrille Marvalin, Alexandre Luneau et al. · Drug Metabolism and Disposition · 2017 · 28 citations · Full text

High-throughput synthesis provides data for predicting molecular properties and reaction success

Julian Götz, Moritz K. Jackl, Chalupat Jindakun et al. · Science Advances · 2023 · 23 citations · Full text

, , +19

Integrated and automated high-throughput purification of libraries on microscale

Carol Ginsburg‐Moraff, Jonathan E. Grob, Karl Chin et al. · SLAS TECHNOLOGY · 2022 · 21 citations · Full text

, , +18

Rows per page

1–5 of 6